Skip to Main Content

Equestrian Athlete Suspended for the Presence of D-Amfetamine

Posted in English riding, Equestrian News, Home Page articles, horse-shows-clinics

Equestrian Athlete Suspended for the Presence of D-Amfetamine

the rider news sunset two horses and a rider

The CCES works collaboratively to ensure Canadians have a positive sport experience.


Ottawa – July 20, 2023 – The Canadian Centre for Ethics in Sport (CCES) announced today that Ben Asselin, an equestrian athlete, received a 14-month sanction for an anti-doping rule violation. The athlete’s urine sample, collected during an in-competition sample collection session on June 18, 2022, revealed the presence of d-amfetamine, a prohibited stimulant.

In response to the CCES’s notification of the adverse analytical finding, the athlete requested a hearing to determine the violation and whether the proposed sanction period should be eliminated or reduced. On June 16, 2023, Arbitrator Robert P. Armstrong confirmed the violation, and reduced the sanction to 14 months on the basis of his finding that Mr. Asselin was not significantly at fault or significantly negligent in connection with the adverse analytical finding. Because the athlete had accepted a voluntary provisional suspension on August 15, 2022, the sanction terminates on October 14, 2023.

During the sanction period, the athlete is ineligible to participate in any capacity with any sport signatory to the Canadian Anti-Doping Program (CADP), including training with teammates.

The full decision can be found at www.crdsc-sdrcc.ca.

About the CCES
The CCES works collaboratively to ensure Canadians have a positive sport experience. Through its programs, the CCES manages unethical issues in sport, protects the integrity of Canadian sport, and promotes True Sport to activate values-based sport on and off the field of play. The CCES is an independent, national, not-for profit organization that is responsible for the administration of the CADP. Under the CADP rules, the CCES makes public every anti-doping rule violation. For more information, visit cces.ca, follow us on Twitter, Facebook, or Instagram.













\

What Our Clients Think

Sign Up For Our Digital Edition

Take The Rider With You Everywhere.

Get Our Digital Edition

905.387.1900 Contact